Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2026

View source ↗

Summary

PRAC evaluated new data on potential risk of neurodevelopmental disorders in children born to men treated with valproate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Disorders
• Neurodevelopmental Disorders

Drugs mentioned

• Valproate (valproate)

Snippet

PRAC concludes evaluation of new data regarding potential risk of neurodevelopmental disorders in children born to men treated with valproate